global view constructed of white lines

Blog

Los Angeles Magazine Top Doctors 2021
April 9, 2021

Pacific Neuroscience Institute Physicians Named “L.A.’s Top Doctors” of 2021

by Caroline Mekhiel

This year, seven of Pacific Neuroscience Institute’s physicians were included in Los Angeles Magazine’s April 2021 roster of “L.A.’s Top Doctors.” The results were based on a Los Angeles Magazine survey that asked physicians throughout Los Angeles County to identify the doctors they considered to be at the...

Oncology Clinical Trials at PNI
March 2, 2021

ONCOLOGY Clinical Trials Round-Up: March 2021

by Mini Gill

New Studies EpicentRx Beta-Prime: A Phase I, First in Human, Study to Evaluate the Safety and Tolerability of AdAPT-001 in Subjects with Refractory Solid Tumors (NCT04673942) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade...

Think Neuro Podcast Cover Dr. Kesari
February 23, 2021

New Hope on Vanquishing Glioblastoma | Dr. Santosh Kesari

by Anthony Effinger

Listen to our conversation with Dr. Kesari to find out what GBM treatments make him believe that big breakthroughs are on the horizon for treating this tricky, and tragic, disease.

PNI 2021
January 1, 2021

PNI Founders’ Message 2021

by Guest Author

Although our medical community continues to strain under the burden of COVID-19, there has been hope, determination and progress. Neurological diseases do not stop and neither have we at Pacific Neuroscience Institute.

November Clinical Trials at PNI
December 2, 2020

Clinical Trials Round-Up: December 2020

by Mini Gill

New Studies Blue Earth Diagnostics FLC-219: (PDF): An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy (PURSUE) (NCT04410367) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A...

November Clinical Trials at PNI
November 2, 2020

Clinical Trials Round-Up: November 2020

by Mini Gill

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Clinical Trials Round Up October 2020 Cover
October 2, 2020

Clinical Trials Round-Up: October 2020

by Mini Gill

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

PNI Super Doctors 2021
September 10, 2020

PNI’s Super Doctors 2021!

by Caroline Mekhiel

Nineteen of PNI’s doctors have been recognized as Super Doctors in the 2021 announcement of this prestigious industry standard award. Of note, Daniel F. Kelly, MD, Founder and Director of PNI, and expert neurosurgeon became a Hall of Fame Super Doctor. With his selection to...

Clinical Trials August 2020 Cover
September 1, 2020

Clinical Trials Round-Up: September 2020

by Mini Gill

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience ( PDF ): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma ( NCT03463265 ) Orbus Therapeutics ( PDF ): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

August 7, 2020

Neurology and Neurosurgery High Performance Recognized at Providence Hospitals and Affiliates

by Zara Jethani

U.S. News & World Report highlights quality, specialty care Ten Providence Southern California hospitals and affiliated partners in Los Angeles and Orange counties earned recognition on July 28, 2020, from U.S. News & World Report. With approximately 415 acute care hospitals in California, the 10...

Last updated: April 19th, 2021